tiprankstipranks
Advertisement
Advertisement

LGND Stock Latest News

Ligand Pharma Shareholders Back Governance and Incentive Plan
Company AnnouncementsLigand Pharma Shareholders Back Governance and Incentive Plan
1d ago
8K
LGND
Ligand price target raised to $266 from $263 at BofA
PremiumThe Fly
Ligand price target raised to $266 from $263 at BofA
14d ago
LGND
TVTX
Ligand Pharmaceuticals Bets Big on Royalty Growth
PremiumCompany Announcements
Ligand Pharmaceuticals Bets Big on Royalty Growth
22d ago
LGND
Ligand Pharma Advances XOMA Royalty Acquisition with Amendment
PremiumCompany Announcements
Ligand Pharma Advances XOMA Royalty Acquisition with Amendment
24d ago
8K
LGND
Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push
PremiumCompany Announcements
Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push
1M ago
LGND
Ligand reports Q1 adjusted EPS $1.63, consensus $1.80
PremiumThe FlyLigand reports Q1 adjusted EPS $1.63, consensus $1.80
1M ago
LGND
Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21
Premium
The Fly
Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21
1M ago
LGND
Orchestra BioMed receives $15M payment from Ligand
Premium
The Fly
Orchestra BioMed receives $15M payment from Ligand
1M ago
LGND
OBIO
LGND Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LGND Earnings this Week: How Will it Perform?
1M ago
LGND
Ligand Pharma Ends TR‑Beta License With Viking Therapeutics
PremiumCompany Announcements
Ligand Pharma Ends TR‑Beta License With Viking Therapeutics
1M ago
8K
LGND
Ligand price target raised to $289 from $243 at H.C. Wainwright
PremiumThe Fly
Ligand price target raised to $289 from $243 at H.C. Wainwright
1M ago
LGND
Ligand price target raised to $252 from $235 at RBC Capital
PremiumThe Fly
Ligand price target raised to $252 from $235 at RBC Capital
1M ago
LGND
Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition
PremiumRatingsAnalyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition
1M ago
LGND
Ligand price target raised to $255 from $230 at Stifel
Premium
The Fly
Ligand price target raised to $255 from $230 at Stifel
1M ago
LGND
XOMA
Ligand price target raised to $260 from $250 at BofA
Premium
The Fly
Ligand price target raised to $260 from $250 at BofA
1M ago
LGND
XOMA
Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio
PremiumCompany Announcements
Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio
1M ago
8K
LGND
Morning Movers: Domino’s Pizza sinks following first quarter results
PremiumThe Fly
Morning Movers: Domino’s Pizza sinks following first quarter results
1M ago
VZ
CPB
Ligand to acquire Xoma for $39.00 per share in cash
PremiumThe Fly
Ligand to acquire Xoma for $39.00 per share in cash
1M ago
LGND
XOMA
Ligand to buy Xoma for $39 per share, WSJ reports
PremiumThe Fly
Ligand to buy Xoma for $39 per share, WSJ reports
1M ago
LGND
XOMA
Ligand price target raised to $282 from $276 at Citi
PremiumThe FlyLigand price target raised to $282 from $276 at Citi
2M ago
LGND
Ligand price target raised to $243 from $239 at H.C. Wainwright
Premium
The Fly
Ligand price target raised to $243 from $239 at H.C. Wainwright
2M ago
LGND
TVTX
This Is Why Travere Therapeutics Stock (TVTX) Surged Today
Premium
Market News
This Is Why Travere Therapeutics Stock (TVTX) Surged Today
2M ago
LGND
TVTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >